RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights

Go back to RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.51 -0.01 (1.92%)
Previous Close $0.52    52 Week High $16.54 
Open $0.53    52 Week Low $8.10 
Day High $0.53    P/E N/A 
Day Low $0.51    EPS $0.00 
Volume 57,418